# Adipose Derived SVF for Aero-digestive & Enterocutaneous Fistulae

> **NCT03792360** · PHASE1 · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Tracheoesopharyngeal Fistula
- Bronchoesophageal Fistula
- Tracheoesophageal Fistula

## Interventions

- **DRUG:** SVF (Stromal Vascular Fraction)

## Key facts

- **NCT ID:** NCT03792360
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-02
- **Primary completion:** 2027-02
- **Final completion:** 2028-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study closed due to lack of patient enrollment.
- **Last updated:** 2023-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03792360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03792360, "Adipose Derived SVF for Aero-digestive & Enterocutaneous Fistulae". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT03792360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*